CoChat
Sign Up
Cited by 249

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses

Orth, Gérard·2006·Seminars in Immunology
DOI 10.1016/j.smim.2006.07.008
Open this paper in CoChat — free account

Abstract

Epidermodysplasia verruciformis (EV) is a rare autosomal recessive genodermatosis associated with a high risk of skin carcinoma. EV results from an abnormal susceptibility to infection by specific human papillomavirus (HPV) genotypes (beta-papillomaviruses) which include the potentially oncogenic HPV5. EV-specific HPVs are considered as harmless for the general population. EV was recently found to be caused by invalidating mutations in two adjacent, related, novel genes, EVER1/TMC6 and EVER2/TMC8. EVER genes encode transmembrane proteins located in the endoplasmic reticulum, which are likely to function as modifiers of ion transporters or channels and to be involved in signal transduction. It was proposed that EV was a primary defect of innate immunity. Our hypothesis is that EVER proteins act as restriction factors for EV-specific HPVs in keratinocytes, and that EV represents a primary deficiency of intrinsic immunity against certain papillomaviruses.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.smim.2006.07.008

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 4 references

Research works printed but not linked: 133

  1. Orth, 2001, Epidermodysplasia verruciformis defines a subset of cutaneous human papillomaviruses, J Virol, 75, 4952, 10.1128/JVI.75.10.4952-4953.2001 · DOI
  2. Lewandowsky, 1922, Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis), Arch Dermatol Syphilol, 141, 193, 10.1007/BF01938833 · DOI
  3. Häusermann, 2002, Das Lewandowsky-Lutz-Syndrom: Die Erstbeschreibung und drei weitere Basler Fälle der Epidermodysplasia verruciformis, Z Hautkr, 77, 176, 10.1046/j.1439-0353.2002.02525.x · DOI
  4. Jablonska, 1972, Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis, Cancer Res, 32, 583
  5. Mashkilleisson, 1931, Ist die Epidermodysplasia verruciformis (Lewandowsky-Lutz) eine selbständige Dermatose? Ihre Beziehungen zur Verrucositas, Dermat Wchnschr, 92, 569
  6. Waisman, 1942, Verruca plana and epithelial nevus, including a study of epidermodysplasia verruciformis, Arch Dermatol Syphilol, 45, 259, 10.1001/archderm.1942.01500080003001 · DOI
  7. Oehlschlaegel, 1966, Die Epidermodysplasia verruciformis, ein sog. Praecancerose, Hautarzt, 10, 450
  8. Hoffmann, 1926, Ûber verallgemeinerte Warzenerkrankung (Verrucosis generalisata) und ihre Beziehung zur Epidermodysplasia verruciformis (Lewandowsky), Dermat Ztschr, 48, 241, 10.1159/000251666 · DOI
  9. Kogoj, 1926, Die Epidermodysplasia verruciformis, Acta Derm Venereol, 7, 170
  10. Sullivan, 1939, Epidermodysplasia verruciformis (Lewandowsky and Lutz), Arch Dermatol Syphilol, 40, 422, 10.1001/archderm.1939.01490030079012 · DOI
  11. Jablonska, 1957, Zur Kenntnis der Epidermodysplasia verruciformis, Dermatologica, 115, 1, 10.1159/000255982 · DOI
  12. Rajagopalan, 1972, Familial epidermodysplasia verruciformis of Lewandowsky and Lutz, Arch Dermatol, 105, 73, 10.1001/archderm.105.1.73 · DOI
  13. Lutz, 1946, A propos de l’épidermodysplasie verruciforme, Dermatologica, 92, 30, 10.1159/000255805 · DOI
  14. Jablonska, 1959, Weitere positive Ergebnisse mit Auto- und Heteroinokulation bei Epidermodysplasia verruciformis Lewandowsky-Lutz, Dermatologica, 118, 86, 10.1159/000255485 · DOI
  15. Jablonska, 1966, On the viral etiology of epidermodysplasia verruciformis, Dermatologica, 132, 369, 10.1159/000254437 · DOI
  16. Ruiter, 1966, Demonstration by electronmicroscopy of an intranuclear virus in epidermodysplasia verruciformis, J Invest Dermatol, 47, 247, 10.1038/jid.1966.137 · DOI
  17. Aaronson, 1967, Epidermodysplasia verruciformis and epidermoid carcinoma: Electron microscopic observations, J Am Med Assoc, 201, 775, 10.1001/jama.201.10.775 · DOI
  18. Jablonska, 1968, On the viral etiology of epidermodysplasia verruciformis Lewandowsky-Lutz: electron microscope studies, Dermatologica, 137, 113, 10.1159/000254038 · DOI
  19. Schellander, 1970, Epidermodysplasia verruciformis: Neue Aspekte zur Symptomatologie und Pathogenese, Dermatologica, 140, 251, 10.1159/000252559 · DOI
  20. Ruiter, 1973, On the histomorphology and origin of malignant cutaneous changes in epidermodysplasia verruciformis, Acta Derm Venereol, 53, 290, 10.2340/0001555553290298 · DOI
  21. Glinski, 1976, Cell-mediated immunity in epidermodysplasia verruciformis, Dermatologica, 153, 218, 10.1159/000251060 · DOI
  22. Prawer, 1977, Depressed immune function in epidermodysplasia verruciformis, Arch Dermatol, 113, 495, 10.1001/archderm.113.4.495 · DOI
  23. Favre, 1975, Human papillomavirus DNA: Physical map, Proc Natl Acad Sci USA, 72, 4810, 10.1073/pnas.72.12.4810 · DOI
  24. Gissmann, 1977, Human papilloma viruses (HPV): Characterization of four different isolates, Virology, 76, 569, 10.1016/0042-6822(77)90239-2 · DOI
  25. Orth, 1977, Characterization of a new type of human papillomavirus that causes skin warts, J Virol, 24, 108, 10.1128/JVI.24.1.108-120.1977 · DOI
  26. Pass, 1977, Identification of an immunologically distinct papillomavirus from lesions of epidermodysplasia verruciformis, J Natl Cancer Inst, 59, 1107, 10.1093/jnci/59.4.1107 · DOI
  27. Orth, 1978, Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis, Proc Natl Acad Sci USA, 75, 1537, 10.1073/pnas.75.3.1537 · DOI
  28. Orth, 1980, Epidermodysplasia verruciformis: A model for the role of papillomaviruses in human cancer, Cold Spring Harbor Conf Cell Prolif, 7, 259
  29. Orth, 1979, Characteristics of the lesions and risk of malignant conversion as related to the type of the human papillomavirus involved in epidermodysplasia verruciformis, Cancer Res, 39, 1074
  30. Ostrow, 1982, Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis, Proc Natl Acad Sci USA, 79, 1634, 10.1073/pnas.79.5.1634 · DOI
  31. Pfister, 1983, Human papillomavirus 5-DNA in carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types, Cancer Res, 43, 1436
  32. Boxman, 1997, Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers, J Invest Dermatol, 108, 712, 10.1111/1523-1747.ep12292090 · DOI
  33. Astori, 1998, Human papillomaviruses are commonly found in normal skin of immunocompetent hosts, J Invest Dermatol, 110, 752, 10.1046/j.1523-1747.1998.00191.x · DOI
  34. Antonsson, 2000, The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses, J Virol, 74, 11636, 10.1128/JVI.74.24.11636-11641.2000 · DOI
  35. Ramoz, 1999, A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus, J Invest Dermatol, 112, 259, 10.1046/j.1523-1747.1999.00536.x · DOI
  36. Ramoz, 2000, Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25, J Invest Dermatol, 114, 1148, 10.1046/j.1523-1747.2000.00996.x · DOI · Paper page
  37. Ramoz, 2002, Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis, Nat Genet, 32, 579, 10.1038/ng1044 · DOI
  38. Bruton, 1952, Agammaglobulinemia, Pediatrics, 9, 722, 10.1542/peds.9.6.722 · DOI · Paper page
  39. Jablonska, 1985, Epidermodysplasia verruciformis, Clin Dermatol, 3, 83, 10.1016/0738-081X(85)90052-5 · DOI
  40. Majewski, 1995, Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin, Arch Dermatol, 131, 1312, 10.1001/archderm.131.11.1312 · DOI
  41. Majewski, 1997, Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression, Clin Dermatol, 15, 321, 10.1016/S0738-081X(96)00169-1 · DOI
  42. Rueda, 1972, Comparacion di la virogenesis en la epidermodisplasia verruciforme y en las verrugas planas, Med Cutan Iber Lat Am, 6, 451
  43. Rueda, 1976, Verrugas humanas por virus papova: Correlacion clinica, histologica y ultraestructural, Med Cutan Iber Lat Am, 2, 113
  44. Jablonska, 1982, Regression of the lesions of epidermodysplasia verruciformis, Br J Dermatol, 107, 109, 10.1111/j.1365-2133.1982.tb00298.x · DOI
  45. Androphy, 1984, Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon, J Am Acad Dermatol, 11, 197, 10.1016/S0190-9622(84)70149-6 · DOI
  46. Lutzner, 1984, Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses, J Invest Dermatol, 83, 18s, 10.1111/1523-1747.ep12281128 · DOI
  47. Gross, 1988, Epidermo-dysplasia verruciformis in a patient with Hodgkin's disease: Characterization of a new papillomavirus type and interferon treatment, J Invest Dermatol, 91, 43, 10.1111/1523-1747.ep12463287 · DOI
  48. Lutzner, 1978, Epidermodysplasia verruciformis: An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis, Bull Cancer, 65, 169
  49. Oliveira, 2003, Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis, J Dermatol, 30, 203, 10.1111/j.1346-8138.2003.tb00372.x · DOI
  50. de Villiers, 2004, Classification of papillomaviruses, Virology, 324, 17, 10.1016/j.virol.2004.03.033 · DOI
  51. Schiffman, 2005, The carcinogenicity of human papillomavirus types reflects viral evolution, Virology, 337, 76, 10.1016/j.virol.2005.04.002 · DOI · Paper page
  52. Deau, 1991, Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes, Virology, 184, 492, 10.1016/0042-6822(91)90419-C · DOI
  53. Favre, 1998, A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis, J Invest Dermatol, 110, 311, 10.1046/j.1523-1747.1998.00164.x · DOI
  54. Schiffman, 2003, Natural history of anogenital human papillomavirus infection and neoplasia, J Natl Cancer Inst Monogr, 31, 14, 10.1093/oxfordjournals.jncimonographs.a003476 · DOI
  55. Tagami, 1985, Regression of flat warts and common warts, Clin Dermatol, 3, 170, 10.1016/0738-081X(85)90062-8 · DOI
  56. Coleman, 1994, Immunological events in regressing genital warts, Am J Clin Pathol, 102, 768, 10.1093/ajcp/102.6.768 · DOI
  57. Frazer, 1999, Potential strategies utilised by papillomavirus to evade host immunity, Immunol Rev, 168, 131, 10.1111/j.1600-065X.1999.tb01288.x · DOI
  58. Woodworth, 2002, HPV innate immunity, Front Biosci, 7, 2058, 10.2741/woodworth · DOI
  59. Offringa, 2003, Interplay between human papillomaviruses and dendritic cells, Curr Top Microbiol Immunol, 276, 215
  60. Stanley, 2006, Immune responses to human papillomavirus, Vaccine, 24S1, S1/16
  61. Bosch, 2002, The causal relation between human papillomavirus and cervical cancer, J Clin Pathol, 55, 244, 10.1136/jcp.55.4.244 · DOI
  62. Schmitt, 1996, The primary target cells of high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells, J Virol, 70, 1912, 10.1128/JVI.70.3.1912-1922.1996 · DOI
  63. Alonso, 2003, Stem cells of the skin epithelium, Proc Natl Acad Sci USA, 100, 11830, 10.1073/pnas.1734203100 · DOI
  64. Fuchs, 2004, Socializing with the neighbors: Stem cells and their niche, Cell, 116, 769, 10.1016/S0092-8674(04)00255-7 · DOI
  65. Münger, 2004, Mechanisms of human papillomavirus-induced oncogenesis, J Virol, 78, 11451, 10.1128/JVI.78.21.11451-11460.2004 · DOI · Paper page
  66. Koromilas, 2001, Control of interferon signaling in human papillomavirus infection, Cytokine Growth Factor Rev, 12, 157, 10.1016/S1359-6101(00)00023-X · DOI
  67. Orth, 2004, Human papillomaviruses and the skin: More to be learned, J Invest Dermatol, 123, XI, 10.1111/j.0022-202X.2004.23243.x · DOI
  68. Kupper, 2004, Immune surveillance in the skin: Mechanisms and clinical consequences, Nat Rev Immunol, 4, 211, 10.1038/nri1310 · DOI
  69. Majewski, 1991, TGFβ-1 and TNFα expression in the epidermis of patients with epidermodysplasia verruciformis, J Invest Dermatol, 97, 862, 10.1111/1523-1747.ep12491539 · DOI
  70. Orth, 1986, Epidermodysplasia verruciformis: A model for understanding the oncogenicity of human papillomaviruses, Ciba Found Symp, 120, 157
  71. Haller, 1995, Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions, Virology, 214, 245, 10.1006/viro.1995.0028 · DOI
  72. Yabe, 1991, A subtype of human papillomavirus 5 (HPV-5b) and its subgenomic segment amplified in a carcinoma: nucleotide sequences and genomic organizations, Virology, 183, 793, 10.1016/0042-6822(91)91013-7 · DOI
  73. Padlewska, 2001, Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis, J Invest Dermatol, 117, 935, 10.1046/j.0022-202x.2001.01515.x · DOI
  74. Storey, 2002, Papillomaviruses: Death-defying acts in skin cancer, Mol Med, 8, 417
  75. de Koning, 2006, Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA, J Clin Microbiol, 44, 1792, 10.1128/JCM.44.5.1792-1800.2006 · DOI
  76. Orth, 2005, Human papillomaviruses associated with epidermodysplasia verruciformis in nonmelanoma skin cancers: Guilty or innocent?, J Invest Dermatol, 125, XII, 10.1111/j.0022-202X.2005.23811.x · DOI
  77. Antonsson, 2003, General acquisition of human papillomavirus infections of skin occurs in early infancy, J Clin Microbiol, 41, 2509, 10.1128/JCM.41.6.2509-2514.2003 · DOI
  78. Stark, 1998, Prevalence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer, J Invest Dermatol, 111, 696, 10.1046/j.1523-1747.1998.00360.x · DOI
  79. Feltkamp, 2003, Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer, Cancer Res, 63, 2695
  80. Kawashima, 1990, Premalignant lesions and cancers of the skin in the general population: Evaluation of the role of human papillomaviruses, J Invest Dermatol, 95, 537, 10.1111/1523-1747.ep12504887 · DOI
  81. Harwood, 2002, Human papillomaviruses and nonmelanoma skin cancer, Curr Opin Infect Dis, 15, 101, 10.1097/00001432-200204000-00002 · DOI
  82. Pfister, 2003, Human papillomavirus and skin cancer, J Natl Cancer Inst Monogr, 31, 52, 10.1093/oxfordjournals.jncimonographs.a003483 · DOI
  83. Brash, 1997, Sunlight and the onset of skin cancer, Trends Genet, 13, 410, 10.1016/S0168-9525(97)01246-8 · DOI
  84. Weissenborn, 1999, High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriasis skin of patients treated or not treated with PUVA, J Invest Dermatol, 113, 122, 10.1046/j.1523-1747.1999.00641.x · DOI
  85. Favre, 2000, Antibodies to human papillomavirus type 5 are generated in epidermal repair processes, J Invest Dermatol, 114, 403, 10.1046/j.1523-1747.2000.00892.x · DOI
  86. Jablonska, 1979, Epidermodysplasia verruciformis versus disseminated verrucae planae: Is epidermodysplasia verruciformis a generalized infection with wart virus?, J Invest Dermatol, 72, 114, 10.1111/1523-1747.ep12530383 · DOI
  87. Glinski, 1981, T-cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus types 3 and 5, Dermatologica, 162, 141, 10.1159/000250262 · DOI
  88. Majewski, 1986, Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis, J Am Acad Dermatol, 15, 966, 10.1016/S0190-9622(86)70258-2 · DOI
  89. Majewski, 1992, Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancers: The role of local immunosurveillance, Am J Med Sci, 304, 174, 10.1097/00000441-199209000-00006 · DOI
  90. Majewski, 1990, Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis, J Am Acad Dermatol, 22, 423, 10.1016/0190-9622(90)70058-P · DOI
  91. Cooper, 1990, Antigen presentation and T-cell activation in epidermodysplasia verruciformis, J Invest Dermatol, 94, 769, 10.1111/1523-1747.ep12874631 · DOI
  92. Koranda, 1974, Cutaneous complications in immunosuppressed renal homograft recipients, J Am Med Assoc, 229, 419, 10.1001/jama.229.4.419 · DOI
  93. Lutzner, 1980, A potentially oncogenic human papillomavirus (HPV5) found in two renal allograft recipients, J Invest Dermatol, 75, 353, 10.1111/1523-1747.ep12531131 · DOI
  94. Lutzner, 1983, Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient, Lancet, 2, 422, 10.1016/S0140-6736(83)90389-6 · DOI
  95. Rüdlinger, 1988, Detection of a human papilloma virus type 5 DNA in a renal allograft patient from Scotland, Dermatologica, 177, 280, 10.1159/000248579 · DOI
  96. Barr, 1989, Human papilloma virus infection and skin cancer in renal allograft recipients, Lancet, 1, 124, 10.1016/S0140-6736(89)91143-4 · DOI
  97. Prose, 1990, Widespread flat warts associated with human papillomavirus type 5: A cutaneous manifestation of human immunodeficiency virus infection, J Am Acad Dermatol, 23, 978, 10.1016/0190-9622(90)70318-C · DOI
  98. Berger, 1991, Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease, Br J Dermatol, 124, 79, 10.1111/j.1365-2133.1991.tb03286.x · DOI
  99. Barzegar, 1998, Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection, Br J Dermatol, 139, 122, 10.1046/j.1365-2133.1998.02328.x · DOI
  100. Gorlin, 2000, WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies, Am J Med Genet, 91, 368, 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9 · DOI
  101. Gulino, 2004, Altered leucocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome, Blood, 104, 444, 10.1182/blood-2003-10-3532 · DOI
  102. Balabanian, 2005, WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12, Blood, 105, 2449, 10.1182/blood-2004-06-2289 · DOI
  103. Laffort, 2004, Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common γc cytokine receptor subunit or JAK-3 deficiency, Lancet, 363, 2051, 10.1016/S0140-6736(04)16457-X · DOI · Paper page
  104. Gaspar, 2004, Severe cutaneous papillomavirus disease after haematopoietic stem-cell transplantation in patients with severe combined immunodeficiency, Br J Haematol, 127, 230
  105. Androphy, 1985, X-linked inheritance of epidermodysplasia verruciformis: Genetic and virologic studies of a kindred, Arch Dermatol, 121, 864, 10.1001/archderm.121.7.864 · DOI
  106. Tate, 2004, Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis, J Hum Genet, 49, 223, 10.1007/s10038-004-0135-6 · DOI
  107. Sun, 2005, A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis, Clin Exp Dermatol, 30, 573, 10.1111/j.1365-2230.2005.01858.x · DOI
  108. Kurima, 2003, Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis, Genomics, 82, 300, 10.1016/S0888-7543(03)00154-X · DOI
  109. Keresztes, 2003, TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins, BMC Genomics, 4, 24, 10.1186/1471-2164-4-24 · DOI
  110. Kurima, 2002, Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function, Nat Genet, 30, 277, 10.1038/ng842 · DOI
  111. Vreugde, 2002, Beethoven, a mouse model for dominant, progressive hearing loss DFNA36, Nat Genet, 30, 257, 10.1038/ng848 · DOI
  112. Noguchi, 2006, Multiple quantitative trait loci modify cochlear hair cell degeneration in the Beethoven (Tmc1Bth) mouse model of progressive hearing loss DFNA36, Genetics, 173, 2111, 10.1534/genetics.106.057372 · DOI
  113. Marcotti, 2006, Tmc1 is necessary for normal functionnal maturation and survival of inner and outer hair cells in the mouse cochlea, J Physiol, 574, 677, 10.1113/jphysiol.2005.095661 · DOI
  114. Han, 1992, Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes, Nature, 356, 66, 10.1038/356066a0 · DOI
  115. Salmon, 2000, Variation in the nucleotide sequence of cottontail rabbit papillomavirus a and b subtypes affects wart regression and malignant transformation and level of viral replication in domestic rabbits, J Virol, 74, 10766, 10.1128/JVI.74.22.10766-10777.2000 · DOI
  116. Breitburd, 1996, HLA control in the progression of human papillomavirus infections, Semin Cancer Biol, 7, 359, 10.1006/scbi.1996.0045 · DOI
  117. Nonnenmacher, 2006, Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis, J Virol, 80, 4890, 10.1128/JVI.80.10.4890-4900.2006 · DOI
  118. DiMaio, 2001, Mechanisms of cell transformation by papillomavirus E5 proteins, Oncogene, 20, 7866, 10.1038/sj.onc.1204915 · DOI
  119. Harry, 1996, Transforming properties of the cottontail rabbit papillomavirus oncoproteins LE6 and SE6 and the E8 protein, J Virol, 70, 3355, 10.1128/JVI.70.6.3355-3362.1996 · DOI
  120. Hu, 2002, Intracutaneous DNA vaccination with the E8 gene of cottontail rabbit papillomavirus induces protective immunity against virus challenge in rabbits, J Virol, 76, 6453, 10.1128/JVI.76.13.6453-6459.2002 · DOI
  121. Palmiter, 1995, Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc, EMBO J, 14, 639, 10.1002/j.1460-2075.1995.tb07042.x · DOI
  122. Frank, 2002, Protocadherins, Curr Opin Cell Biol, 14, 557, 10.1016/S0955-0674(02)00365-4 · DOI
  123. Angel, 2001, Function and regulation of AP-1 subunits in skin physiology and pathology, Oncogene, 20, 2413, 10.1038/sj.onc.1204380 · DOI
  124. Bieniasz, 2004, Intrinsic immunity: A front-line defense against viral attack, Nat Immunol, 5, 1109, 10.1038/ni1125 · DOI
  125. Van der Leest, 1987, Human papillomavirus heterogeneity in 36 renal transplant recipients, Arch Dermatol, 123, 354, 10.1001/archderm.123.3.354 · DOI
  126. Obalek, 1992, Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients, J Invest Dermatol, 98, 936, 10.1111/1523-1747.ep12460892 · DOI
  127. Notarangelo, 2004, Primary immunodeficiency diseases: An update, J Allergy Clin Immunol, 114, 677, 10.1016/j.jaci.2004.06.044 · DOI
  128. Casanova, 2004, The human model: a genetic dissection of immunity to infection in natural conditions, Nat Rev Immunol, 4, 55, 10.1038/nri1264 · DOI
  129. Fischer, 2004, Human primary immunodeficiency diseases: a perspective, Nat Immunol, 5, 23, 10.1038/ni1023 · DOI
  130. Casanova, 2005, From idiopathic infectious diseases to novel primary immunodeficiencies, J Allergy Clin Immunol, 116, 426, 10.1016/j.jaci.2005.03.053 · DOI
  131. Archard, 1965, Focal epithelial hyperplasia: An unusual oral mucosal lesion found in Indian children, Oral Surg Oral Med Oral Pathol, 20, 201, 10.1016/0030-4220(65)90192-1 · DOI
  132. Beaudenon, 1987, A new type of human papillomavirus associated with oral focal epithelial hyperplasia, J Invest Dermatol, 88, 130, 10.1111/1523-1747.ep12525278 · DOI
  133. Premoli-De-Percoco, 1993, Focal epithelial hyperplasia: Human-papillomavirus-induced disease with a genetic predisposition in a Venezuelan family, Hum Genet, 91, 386, 10.1007/BF00217363 · DOI

Cited by

Metadata

Authors
Orth, G.
Venue
Seminars in Immunology
Publisher
Elsevier BV
Published
2006-12
Volume
18
Issue
6
Pages
362-374
ISSN
1044-5323
DOI
10.1016/j.smim.2006.07.008
Cited by
249
References
4
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review